PHILADELPHIA, Dec. 15, 2009 — The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce the full agenda for the 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress. The forum will take place at the Loews Philadelphia, on March 16-17, 2010.
Over 1,500 senior-level Finance, Accounting, Audit and Reporting professionals have attended this premier event since its inception, and this year’s meeting will provide updates on changing regulations, technical accounting guidelines, auditing strategies and financial reporting best practices. Most importantly, it is uniquely tailored for the specific challenges and requirements of pharmaceutical and biotech companies. Agenda topics include:
- Critical Accounting/Financial Reporting Issues in 2010-2011
- SEC Hot Topics and Current Issues Impacting Pharmaceutical and Biotech Companies
- IFRS Updates
- Pharma and Life Sciences Industry Transactions: Strategy, Structures and Key Accounting Issues
CBI’s 2010 Accounting and Reporting Congress is sponsored by Deloitte, PricewaterhouseCoopers, Duff & Phelps, Ernst & Young, PharmaMetrics, Vistacom, ClearTrial and KPMG. To view the full agenda, please visit http://www.cbinet.com/accounting. If you would like to apply for a press pass, please contact of CBI at 339.298.2263.
About CBI
A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.
# # #
